WINDLAS BIOTECH
Back to Cashflow Statement
|
WINDLAS BIOTECH Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹68 Cr | ₹109 Cr | ₹61 Cr | ₹9.13 Cr | ₹11 Cr |
What is the latest Cash Flow from Operating Activities ratio of WINDLAS BIOTECH ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹68 Cr |
| Mar2024 | ₹109 Cr |
| Mar2023 | ₹61 Cr |
| Mar2022 | ₹9.13 Cr |
| Mar2021 | ₹11 Cr |
How is Cash Flow from Operating Activities of WINDLAS BIOTECH Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹68 Cr | -37.42 | |
| Mar2024 | ₹109 Cr | 78.73 | |
| Mar2023 | ₹61 Cr | 567.74 | |
| Mar2022 | ₹9.13 Cr | -20.30 | |
| Mar2021 | ₹11 Cr | - | |
Compare Cash Flow from Operating Activities of peers of WINDLAS BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WINDLAS BIOTECH | ₹1,611.1 Cr | -7% | -6.1% | -22.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹451,075.0 Cr | 0.9% | 12.8% | 4.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,486.0 Cr | 3.2% | 14% | 13.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,124.0 Cr | 0.7% | 5.5% | 36.9% | Stock Analytics | |
| CIPLA | ₹115,641.0 Cr | 6.8% | 18.8% | -10.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,589.0 Cr | 0.7% | 5.5% | 9.4% | Stock Analytics | |
WINDLAS BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WINDLAS BIOTECH | -7% |
-6.1% |
-22.4% |
| SENSEX | -3.1% |
-2.8% |
-6.1% |
You may also like the below Video Courses